Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ: 007370)

Market Cap	58.57B
Revenue (ttm)	103.60B
Net Income (ttm)	9.81B
Shares Out	11.35M
EPS (ttm)	714.00
PE Ratio	7.23
Forward PE	n/a
Dividend	150.00 (2.86%)
Ex-Dividend Date	n/a

Volume	159,275
Open	5,210.00
Previous Close	5,250.00
Day's Range	5,210.00 - 5,360.00
52-Week Range	4,860.00 - 8,100.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Jin Yang Pharmaceutical

Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers products for anti-diabetics, antivirals, anti-hypertensives, anti-coagulants, antihistamines, antipyretics, and analgesics; digestive, respiratory, and neuropsychiatric system. It also provides drugs for genito-urinary system, anti-osteoporosis drugs, antimicrobials and antibiotics; and over the counter drugs antipyretics and analgesics. It also provides products for digestive, genito-urinary, neuropsychiatric, circulatory, and dermatolog...

• Industry: Pharmaceutical Preparations
• Founded: 1971
• Employees: 220
• Stock Exchange: KOSDAQ
• Ticker Symbol: 007370

Financial Performance

In 2023, Jin Yang Pharmaceutical's revenue was 94.11 billion, an increase of 23.40% compared to the previous year's 76.26 billion. Earnings were 12.66 billion, an increase of 2.85%.